Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

43 44 Next >

$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today ↗

July 25, 2024

Via Benzinga

Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program

July 25, 2024

From DexCom, Inc.

Via Business Wire

Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗

July 19, 2024

Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...

Via Benzinga

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?. ↗

July 15, 2024

DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?.

Via Chartmill

2 Healthcare Stocks to Buy at a Discount ↗

July 14, 2024

Beaten-down stocks can sometimes present an opportunity.

Via The Motley Fool

What Analysts Are Saying About DexCom Stock ↗

July 12, 2024

Via Benzinga

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

July 05, 2024

Via Benzinga

Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase. ↗

June 24, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today ↗

June 17, 2024

Via Benzinga

Top 4 Must-Have Healthcare Stocks for Long-Term Growth

July 11, 2024

Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand.

Via MarketBeat

3 Breakthrough Medical Device Stocks to Invest In Now ↗

July 08, 2024

Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead.

Via InvestorPlace

2 Top Growth Stocks to Buy With $1,000 ↗

July 04, 2024

These stocks have excellent track records of beating the market.

Via The Motley Fool

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

June 27, 2024

From DexCom, Inc.

Via Business Wire

Peering Into DexCom's Recent Short Interest ↗

June 11, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today ↗

June 03, 2024

Via Benzinga

In-Depth Examination Of 6 Analyst Recommendations For DexCom ↗

May 30, 2024

Via Benzinga

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034 ↗

June 25, 2024

These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact.

Via InvestorPlace

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey ↗

June 21, 2024

Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio.

Via InvestorPlace

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

June 20, 2024

From DexCom, Inc.

Via Business Wire

The 3 Best Diabetes Stocks to Buy in June 2024 ↗

June 19, 2024

There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy.

Via InvestorPlace

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

May 30, 2024

Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024) ↗

June 16, 2024

Via Benzinga

Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom ↗

June 10, 2024

The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.

Via Investor's Business Daily

Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor ↗

June 09, 2024

Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone.

Via Benzinga

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

June 05, 2024

From DexCom, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2024

Via Benzinga

Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems

June 03, 2024

From Dexcom, Inc.

Via Business Wire

Bull Market Buys: 2 Growth Stocks to Own for the Long Haul ↗

June 03, 2024

Innovation is paying off for both of these medical device specialists.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 31, 2024

Via Benzinga

Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? ↗

May 30, 2024

Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today